A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.

Maria Assunta Zocco, Francesco Franceschi, Giovanni Cammarota, Giovanni Battista Gasbarrini, Antonio Gasbarrini, Enrico Celestino Nista, Marcello Candelli, Filippo Cremonini, Immacolata Alessia Cazzato

Risultato della ricerca: Contributo in rivistaArticolo in rivista

138 Citazioni (Scopus)

Abstract

The incidences of nausea, diarrhoea and epigastric pain in patients treated with B. clausii were significantly lower than in placebo group, in both PP and ITT analysis. Equally, intensity of nausea and diarrhoea in patients treated with B. clausii was significantly lower than in placebo group. There were no differences in adherence to treatment and H. pylori eradication rates between groups. Conclusion : In symptom-free, H. pylori-positive subjects B. clausii bacteriotherapy reduces the incidence of the most common side-effects related to anti-H. pylori antibiotic therapy compared with placebo
Lingua originaleEnglish
pagine (da-a)1181-1188
Numero di pagine8
RivistaALIMENTARY PHARMACOLOGY & THERAPEUTICS
Stato di pubblicazionePubblicato - 2004

Keywords

  • Bacillus clausii
  • HP

Fingerprint Entra nei temi di ricerca di 'A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.'. Insieme formano una fingerprint unica.

Cita questo